SPAC Overview
$173M
IPO Size
$175M
Trust (as of 2026-06-30)
IPO
Current Status
2026
IPO Year
Timeline Progress
About
Helix Acquisition Corp. III is a blank-check company seeking to complete an initial business combination with an unidentified business. It intends to focus on healthcare or healthcare-related industries.
Investment Focus
Healthcare
The terms and the filing trail behind Helix Acquisition Corp. III
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
Led by Chairperson and CEO Bihua Chen, CFO and COO Caleb Tripp, and CLO Nebojsa Obradovic, with director nominees Mark McKenna and John Schmid. The team has life-sciences and medical-technology experience and prior SPAC experience; Chen founded Cormorant, a healthcare-focused investment firm.
Stock Performance
HLXC
Trading Symbol
First Trade
January 23, 2026
$10.24
Current Price
September 30, 2026
$10.62
+4%
Key Information
IPO Date
January 23, 2026
State of Incorporation
E9
SIC
6770
SPAC Ticker
HLXC